1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one-D4;1-[1-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-2H-benzimidazol-2-one-d4; Dehydrobenzperidol-d4; Dridol-d4; Droleptan-d4; Inapsin-d4; Inapsine-d4; Inopsin-d4; McN-JR 4749; NSC 169874; Neurolidol-d4; R 474; Sintodril-d4;Droperidol-d4
Droperidol-d4 is a fully characterized chemical compound used as a reference standard of API Droperidol. The standard offered is compliant with regulatory guidelines. Droperidol-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 548-73-2 (non-d)
